Mitchell E. Horwitz, MD, discussed how omidubicel and other advances in allogeneic transplantation have affected different hematologic oncology populations.
Mitchell E. Horwitz, MD
Advertisement
Articles by Mitchell E. Horwitz, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
EC Expands Enfortumab Vedotin/Pembrolizumab Approval for Resectable MIBC
2
Efficacy and Safety of Immune Checkpoint Inhibitors Combined With Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer
3
Which Head and Neck Cancer Data Should You Watch For at ESMO 2026?
4
Sofetabart Mipitecan Shows Activity Across FRα Expression Levels in PROC
5